Page last updated: 2024-08-21

nicotinamide mononucleotide and Atherosclerotic Parkinsonism

nicotinamide mononucleotide has been researched along with Atherosclerotic Parkinsonism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guo, SQ; Hu, ZW; Li, WL; Zou, XD	1

Other Studies

1 other study(ies) available for nicotinamide mononucleotide and Atherosclerotic Parkinsonism

Article	Year
NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity. Molecular medicine reports, 2016, Volume: 13, Issue:5 Topics: Acrylamides; Animals; Cell Survival; Cytokines; L-Lactate Dehydrogenase; Malondialdehyde; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Piperidines; Rats; Sirtuin 1	2016

Article

Year

NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity.

Molecular medicine reports, 2016, Volume: 13, Issue:5

Topics: Acrylamides; Animals; Cell Survival; Cytokines; L-Lactate Dehydrogenase; Malondialdehyde; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Piperidines; Rats; Sirtuin 1

2016